Chad Howell
About Chad Howell
Chad Howell is a Sr. Immuno-Oncology Specialist at Bristol-Myers Squibb with over 18 years of experience in the pharmaceutical industry.
Title
Chad Howell holds the title of Sr. Immuno-Oncology Specialist at Bristol-Myers Squibb. With an emphasis on Immuno-Oncology, he focuses on advanced cancer treatments and innovative therapeutic approaches.
Company
Chad Howell currently works for Bristol-Myers Squibb, a global pharmaceutical company known for its pioneering research and drug development in the field of Immuno-Oncology. Howell has been part of the organization for over 8 years.
Education and Expertise
Chad Howell studied Advertising at West Virginia University, where he earned a Bachelor of Science (B.S.) degree from 1987 to 1991. With over 18 years in the pharmaceutical industry, Howell's expertise spans sales, therapeutic specialties, and Immuno-Oncology.
Previous Experience
Before joining Bristol-Myers Squibb, Chad Howell worked at Sunovion Pharmaceuticals as a Sr. Therapeutic Specialist from 2010 to 2013. Prior to that, he was a Sr. Sales Representative at sanofi-aventis from 2004 to 2009. His career has been based in the Charleston-Huntington area.
Background
Chad Howell has dedicated over 18 years to the pharmaceutical industry, building extensive experience in sales and therapeutic specialties. His deep understanding of Immuno-Oncology has enabled him to contribute to innovative approaches in cancer treatment. Howell's professional journey includes significant roles at Sunovion Pharmaceuticals and sanofi-aventis before his current position at Bristol-Myers Squibb.